Citadel Advisors’s Imunon IMNN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNN
XT
VHAM
TRCT
Citadel Advisors's IMNN Position: Q1 2025 in Review
Citadel Advisors sold out of Imunon (IMNN) in Q1 2025, closing a stake of 983 shares — an estimated $12.2K sold.
Citadel Advisors first reported a position in IMNN in Q2 2013 and held it in 32 quarters. The position peaked at $166K in Q1 2022. 16 funds tracked by Wall St. Rank hold IMNN as of Q1 2025.
- Citadel Advisors reported no remaining Imunon position as of Q1 2025 after selling out during the quarter.
- Citadel Advisors sold 983 Imunon shares in Q1 2025, an estimated $12.2K.
- Citadel Advisors first reported a position in Imunon in Q2 2013 and held it in 32 quarters.
- Citadel Advisors's Imunon position peaked at $166K in Q1 2022.
- 16 funds tracked by Wall St. Rank held Imunon as of Q1 2025.
Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.